This report provides a snapshot of the innovative programs we have initiated and conducted on behalf of the Commonwealth of Massachusetts. Our team has generated revenue and achieved cost avoidance totaling $26 billion over a 15-year period. Much can be accomplished when the family of state agencies in Massachusetts collaborate and combine their strengths to better serve the public.
Pipeline Trends features concise, impartial data on drugs in development and their potential place in therapy. This issue includes updates on aclidinium bromide, aflibercept, dimethyl fumarate, elvitegravir, and other new drugs.